With regional differences in which name is used for the aortic fix, some say unity is needed. Others can live with both.

Evolut showed less bioprosthetic valve dysfunction, prosthetic valve thrombosis and haemodynamic structural valve dysfunction ...

DurAVR ® THV demonstrated a favorable hemodynamic profile sustained to one-year, with an Effective Orifice Area (EOA) of 2.1 + 0.2 cm 2, a Mean Pressure Gradient (MPG) of 8.6 + 2.6 mmHg and Doppler ...

WASHINGTON, DC—Updated data from the SMART trial show that supra-annular self-expanding valves yield similar clinical outcomes as balloon-expandable valves at 2 years, but with less risk of ...

A recent editorial claimed that “it’s time to act” in asymptomatic patients with severe aortic stenosis (AS). The expert authors, including eminent cardiologist Eugene Braunwald, MD ...

The preliminary results look promising for the Evolut for specific patients. The trial consists of mostly women, who have ...

Persistent breathlessness, exhaustion, and a life where physical activity feels impossible – these may be signs of a heart struggling to keep up. At Institut Jantung Negara (IJN), Malaysia’s ...

CRT 2025 Late Breaking Science features largest head-to-head randomized control TAVR trial to primarily enroll women using the two most widely used global TAVR devices GALWAY, Ireland and ...

(RTTNews) - Medtronic plc (MDT) released the two-year results of the SMall Annuli Randomized To Evolut or SAPIEN (SMART) Trial, international head-to-head comparative trial of transfemoral ...

Mechanical heart valves have improved long-term survival benefit over biological valves for patients aged 50-70 years, new ...

Clinical suitability is the primary requirement for selection of a patient for TAVI. Although TAVI compares favorably to conservative treatment in patients at high risk of or inoperable by ...